Skip to main content

Louis Bar Syndrome clinical trials at UC Health
1 research study open to eligible people

  • N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

    open to eligible people ages 6 years and up

    This is a multinational, multicenter, open-label, rater-blinded prospective Phase II study which will assess the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the treatment of Ataxia-Telangiectasia (A-T).

    at UCLA

Last updated: